Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
NCT ID:
NCT02129556
Group ID:
EG001
Title:
Phase II (PD-L1+ and PD-L1-)
Description:
HER2-positive, PD-L1 expressing or PD-L1 negative, unresectable loco-regional or metastatic breast carcinoma that progressed on prior trastuzumab-based therapy. For adverse events, Phase II cohorts were combined since PD-L1 status does not affect toxicity.
Deaths Number Affected:
25
Deaths Number At Risk:
None
Serious Number Affected:
25
Serious Number At Risk:
52
Other Number Affected:
50
Other Number At Risk:
52
Study:
NCT02129556
Results Section:
NCT02129556
Adverse Events Module:
NCT02129556